STAHL NEIL 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Aug 6, 2024
Insider Transaction Report
Form 4
STAHL NEIL
SVP Res and Dev Sciences
Transactions
- Exercise/Conversion
Common Stock
2024-08-02$555.67/sh+23,638$13,134,927→ 74,637 total - Tax Payment
Common Stock
2024-08-02$1093.49/sh−18,441$20,165,049→ 56,196 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-08-02−23,638→ 45,000 totalExercise: $555.67Exp: 2025-12-16→ Common Stock (23,638 underlying)
Holdings
- 5,849(indirect: By 401(k))
Common Stock
- 4,605(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The stock option award vests in four equal annual installments, commencing one year after the date of grant.